PharmaBioSource provided exclusive marketing and consulting services to sell AMRI’s small molecule API manufacturing operation located in Lodi, Italy. The Lodi operation known as Prime European Therapeutics S.p.A. (Euticals) was acquired by LIVIA Corporate Development, which specializes in acquiring European Corporate spin-offs/carve-outs. The Lodi site is specialized for the custom synthesis and manufacture of active pharmaceutical ingredients (APIs).

PharmaBioSource Realty provided exclusive real estate services to identify and negotiate the lease for the former Teva Chemical Synthesis Center in Malvern, PA located just outside of Philadelphia.  PharmaBioSource also provided start-up and logistics services to assist Flamma in occupying the 40,000 SF facility.

PharmaBioSource provided exclusive marketing and consulting services to sell AMRI’s sterile injectables manufacturing operation located in León, Spain. The León operation was acquired by Lyophilization Services of New England (LSNE), which will enable it to expand its reach into Europe. The León facility includes four high-speed, automated aseptic fill lines and commercial scale lyophilization for the manufacture of clinical and commercial drug products.